Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

INTRODUCTION: The incidence of herpes zoster (HZ) rises steeply after the age of 50 years and the number of HZ cases and complications such as postherpetic neuralgia (PHN) is predicted to increase because of the ageing population. The objective of this study was to estimate the cost-effectiveness of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatol Ther (Heidelb)
Hauptverfasser: Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522608/
https://ncbi.nlm.nih.gov/pubmed/30929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-0291-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge